Cardiac Inflammation Research Group
21 – 30 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
IL1RAP Blockade with a Monoclonal Antibody Reduces Cardiac Inflammation and Preserves Heart Function in Viral and Autoimmune Myocarditis
- Contribution to journal › Article
-
Mark
Increasing plasma calprotectin (S100A8/A9) is associated with 12-month mortality and unfavourable functional outcome in critically ill COVID-19 patients
- Contribution to journal › Article
-
Mark
Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome
- Contribution to journal › Article
-
Mark
Mechanistic and therapeutic studies in cardiac inflammation
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population
- Contribution to journal › Article
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. Reply
- Contribution to journal › Letter
-
Mark
Short-term S100A8/A9 Blockade Promotes Cardiac Neovascularization after Myocardial Infarction
(2024) In Journal of Cardiovascular Translational Research
- Contribution to journal › Article
- 2023
-
Mark
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
- Contribution to journal › Article
-
Mark
Long-term Safety of Revascularization Deferral Based on Instantaneous Wave-Free Ratio or Fractional Flow Reserve
- Contribution to journal › Article
-
Mark
Prevalence of angina pectoris and association with coronary atherosclerosis in a general population
- Contribution to journal › Article
